e.ferreira
TL3 Regular · Porto, PT
Clinical trials coordinator. I can usually explain why a protocol looks strange from outside.
Joined 5 December 2024 · last posted 2d · groups: journal-club
4 replies marked as the accepted answer.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #9 · marked as the solution · Compounds › Retatrutide · 25 Mar 2025 · 8 likes On Retatrutide mass and identity: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #3 · marked as the solution · Practice › Reconstitution · 29 Mar 2026 · 7 likes Worth separating 5 mg vial as a question about the compound from 5 mg vial as a question about the documentation. They get answered by different people and only one of…
-
Warfarin and altered intake: the monitoring argument Replied, post #2 · marked as the solution · Practice › Interactions · 8 Jan 2026 · 11 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
What a reversed-phase purity number actually is Replied, post #5 · marked as the solution · Analytics › HPLC & UHPLC · 26 Jun 2026 · 17 likes Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…